OFIX has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
OFIX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Orthofix Medical has the Profitability Rank of 4.
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way. It is based on these factors:
1. Operating Margin %Orthofix Medical's Operating Margin % for the quarter that ended in Mar. 2024 was -12.69%. As of today, Orthofix Medical's Piotroski F-Score is 2.
For the Medical Devices subindustry, Orthofix Medical's Profitability Rank, along with its competitors' market caps and Profitability Rank data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, Orthofix Medical's Profitability Rank distribution charts can be found below:
* The bar in red indicates where Orthofix Medical's Profitability Rank falls into.
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.
The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.
Orthofix Medical has the Profitability Rank of 4.
Profitability Rank is not directly related to the Financial Strength. But if a company is consistently profitable, its financial strength will be stronger.
Profitability Rank is based on these factors:
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
Orthofix Medical's Operating Margin % for the quarter that ended in Mar. 2024 is calculated as:
Operating Margin % | = | Operating Income (Q: Mar. 2024 ) | / | Revenue (Q: Mar. 2024 ) |
= | -23.941 | / | 188.608 | |
= | -12.69 % |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Warning Sign:
Piotroski F-Score of 2 is low, which usually implies poor business operation.
The zones of discrimination were as such:
Good or high score = 8 or 9
Bad or low score = 0 or 1
Orthofix Medical has an F-score of 2. It is a bad or low score, which usually implies poor business operation.
3. Trend of the Operating Margin % (5-year average). The company with an uptrend profit margin has a higher rank.
4. Consistency of the profitability
5. Predictability Rank
Thank you for viewing the detailed overview of Orthofix Medical's Profitability Rank provided by GuruFocus.com. Please click on the following links to see related term pages.
James F. Hinrichs | director | 3750 TORREY VIEW COURT, SAN DIEGO CA 92130 |
Puja Leekha | officer: CECO & Interim CLO | 3451 PLANO PARKWAY, LEWISVILLE TX 75056 |
Geoffrey C Gillespie | officer: VP, Controller, Interim CFO | 3451 PLANO PARKWAY, LEWISVILLE TX 75056 |
Kevin J. Kenny | officer: President of Global Spine | C/O CARDIOVASCULAR SYSTEMS, INC., 1225 OLD HIGHWAY 8 NW, ST. PAUL MN 55112 |
Shweta Maniar | director | C/O SEASPINE HOLDINGS CORP, 5770 ARMADA DRIVE, CARLSBAD CA 92008 |
Stuart Essig | director | 311 C ENTERPRISE DRIVE, PLAINSBORO NJ 08536 |
John J. Bostjancic | officer: CFO | C/O SEASPINE HOLDINGS CORPORATION, 2302 LA MIRADA DRIVE, VISTA CA 92081 |
Keith Valentine | director, officer: President & CEO | 7475 LUSK BLVD., SAN DIEGO CA 92121 |
Henneman John B Iii | director | 311 C ENTERPRISE DRIVE, PLAINSBORO NJ 08536 |
Patrick L Keran | officer: Chief Legal Officer | 6725 MESA RIDGE RD., SUITE 100, SAN DIEGO CA 92121 |
Thomas A. West | director | C/O INTERSECT, INC., 1555 ADAMS DRIVE, MENLO PARK CA 94025 |
Michael E Paolucci | director | 7475 LUSK BLVD., SAN DIEGO CA 92121 |
Catherine M Burzik | director | |
Rice Doug | officer: CFO | 3451 PLANO PARKWAY, LEWISVILLE TX 75056 |
Kimberley A. Elting | officer: Chief Legal Officer | 3451 PLANO PARKWAY, LEWISVILLE TX 75056 |
From GuruFocus
By Business Wire • 11-28-2023
By Marketwired • 10-11-2023
By Business Wire • 11-06-2023
By PRNewswire • 10-09-2023
By PRNewswire • 10-18-2023
By Marketwired • 11-04-2023
By Business Wire • 12-12-2023
By PRNewswire • 10-12-2023
By Business Wire • 11-29-2023
By Business Wire • 01-18-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.